Maynard Um
-
-
-
-
-
-
-
Telomir Pharmaceuticals completes TELI acquisition for global drug rights
-
-
-
-
-
-
-
Rodman & Renshaw Starts Telomir Pharma (TELO) at Buy
-
-
-
-
-
-
-
Telomir reports drug candidate shows activity against leukemia cells
-
-
-
-
-
-
-
Telomir Pharmaceuticals Executes Binding LOI for Worldwide Rights to Telomir-1, Positioning the Company for Global Market Expansion and Value Growth
-
-
-
-
-
-
-
Telomir Pharmaceuticals reports preclinical cancer findings
-
-
-
-
-
-
-
Telomir Pharmaceuticals Announces In Vitro Data Showing Telomir-1 Inhibits Key Epigenetic Enzymes Driving Tumor Growth, Autoimmune Disease, Neurodegeneration, and Metabolic Dysfunction
-
-
-
-
-
-
-
Telomir Pharmaceuticals (TELO) Announces Telomir-1 Demonstrates Dose-Dependent Restoration of Neurological, Liver and Kidney Functions
-
444,315 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

